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Background: Sulfur mustard can cause several long-term complications in the organs of 
  individuals exposed to this toxic gas, and among these, pulmonary sequelae are the most 
  important. More than 25 years after the Iran–Iraq war, thousands of Iranians are suffering 
from the chronic respiratory complications of sulfur mustard. Currently, based on several 
clinical findings, bronchiolitis obliterans is confirmed as the major diagnosis in these patients. 
  Numerous studies have revealed that this disorder is strongly associated with oxidative stress 
due to excessive production of harmful reactive substances and decreased levels of endogenous 
antioxidants. Metallothioneins (MTs) are a group of low molecular weight sulfhydryl-rich intra-
cellular proteins, and several isoforms have been identified in humans. MT-1A is an inducible 
and important MT isoform, which is transcriptionally activated by a variety of stress stimuli, 
such as free radicals.
Methods: MT-1 mRNA expression and protein levels in endobronchial biopsy samples from 
24 sulfur mustard-exposed patients and 15 unexposed control cases were evaluated by semi-
quantitative reverse transcriptase polymerase chain reaction, real-time reverse transcriptase 
polymerase chain reaction, and immunohistochemistry.
Results: mRNA- MT-1A expression levels in sulfur mustard-exposed patients were upregulated 
compared with normal samples. Protein expression was also markedly higher in controls than 
in sulfur mustard-exposed patients.
Conclusion: Upregulation of MT-1A mRNA in patients who have been exposed to sulfur 
mustard seems to be due to oxidative stress, which is induced in an attempt to ameliorate this 
harmful situation by reestablishment of homeostasis, but depletion of its protein might be due 
to secondary consequences of sulfur mustard toxicity, which are as yet not understood.
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Introduction
Respiratory system sequelae are the most important long-term complications in patients 
exposed to sulfur mustard. Thousands of Iranian civilians and veterans are still suffer-
ing from delayed respiratory difficulties caused by inhalation of this toxic gas during 
the Iraq conflict with Iran more than 25 years ago.1,2
Cough, dyspnea, excessive sputum production, and hemoptysis are among the 
most prominent chronic pulmonary symptoms in sulfur mustard-injured patients.3,4 
Nowadays, bronchiolitis obliterans is part of the diagnosis in these patients.5 However, 
a number of differences have been found between this kind of bronchiolitis obliterans 
and other kinds, such as that following lung transplantation, and there is no progres-
sion   pattern, rare fibrosis, differing severity, and less obliteration.6 Investigations have International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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shown that the pulmonary disorder in patients with chronic 
sulfur mustard exposure is strongly associated with oxidative 
stress, caused by an imbalance between excessive creation 
of reactive oxygen and/or nitrogen species and depletion of 
endogenous antioxidants,7 along with the release of several 
kinds of inflammatory mediators from a number of cell 
types.8,9 A recent study has shown that serum glutathione 
levels are significantly lower in patients exposed to sulfur 
mustard than in controls, but the level of malondialdehyde 
is significantly higher in sulfur mustard victims.10 More 
recently, in a study of airway biopsy samples, we demon-
strated that expression of lipocalin-2 at the mRNA level was 
significantly higher in sulfur mustard-injured patients in 
comparison with controls, but there was no significant differ-
ence in the expression of lipocalin-2 protein between patients 
and controls.11 These data confirm that oxidative stress due 
to excessive production of harmful reactive substances and 
decreased levels of endogenous protective antioxidants is a 
phenomenon in these patients that plays a pivotal role in the 
pathology of late pulmonary complications of sulfur mustard 
exposure. However, the exact mechanisms still need to be 
elucidated.
Metallothioneins (MTs) are a group of low molecular 
weight (6–7 kDa), sulfhydryl-rich intracellular proteins 
with 61 to 68 amino acid residues, initially recognized by 
  Margoshes and Vallee in 1957 as cadmium-binding pro-
teins in equine kidney tissue. In human beings, several MT 
isoforms, from MT-1 through MT-4, have been identified.12 
MT-1 is an inducible MT isoform encoded by a group of 
more than 10 functional genes, amongst which MT-1A is 
a broadly disseminated MT isoform in the human body. Its 
transcription is activated by a variety of stress stimuli, includ-
ing metals, glucocorticoids, a number of proinflammatory 
cytokines, and reactive oxygen species.13,14   Intracellular metal 
homeostasis, heavy metal detoxification, and scavenging of 
a wide variety of compounds, including hydroxyl radicals, 
superoxide, hydrogen peroxide, and nitric oxide, are among 
the accepted roles of MT-1, although the exact molecular 
mechanisms involved are not fully understood.15,16
A number of studies have demonstrated coexpression of 
MT-1 and lipocalin-2 in some illnesses, including oxidative 
stress-mediated lung injuries.17 The present study aimed to 
assess the expression of MT-1A at the mRNA and protein 
levels in bronchial biopsy samples of sulfur mustard-injured 
patients in comparison with controls. Our results may 
pave the way to new treatments for the chronic respiratory 
  complications encountered in these patients.
Material and methods
study design
Twenty-four sufferers of chronic respiratory sequelae from 
exposure to sulfur mustard during the 1980–1988 Iran–Iraq 
war were enrolled as the sulfur mustard-exposed group 
and 15 unexposed individuals as the control group. All of the 
subjects were male. Contact with sulfur mustard was confirmed 
by documents from the Iranian military health services at the 
time of exposure. These victims all developed pulmonary 
symptoms immediately after contact with sulfur mustard, 
without any symptom-free periods. The study was approved 
by the ethics committee of the Baqiyatallah   University of 
Medical Sciences. The procedures conformed to the guiding 
principles of the Declaration of Helsinki, and all subjects 
signed informed consent forms for participation in the study. 
Potential subjects having other interactive criteria, as well as 
those involving other chronic pulmonary diseases (eg, asthma), 
autoimmune disease (eg, rheumatoid arthritis), lung cancer, 
diabetes mellitus, acute infective bronchitis, or pneumonia, 
were excluded. Drug addicts, elderly people (>65 years old), 
smokers, organ transplant recipients, and patients with a his-
tory of occupational pulmonary exposure to other toxic agents 
were also excluded. Age, gender, and pulmonary function 
test data for the two groups are shown in Table 1.
All subjects were anesthetized by inhalation of 2% 
aerosolized lidocaine and intravenous midazolam, and slept 
Table 1 characteristics and pulmonary function test results of sM-injured patient and control group
Control group subjects 
n = 15
SM-injured patients 
n = 24
P value
Age range 22–57 30–58 –
Age (mean ± sD) 43.6 ± 10.92 42.9 ± 5.48 0.83 
FVc (mean ± sD) 3.34 ± 0.79 2.87 ± 0.89 0.11 
FeV1 (mean ± sD) 2.71 ± 0.81 1.92 ± 0.87 0.007*
FeV1/FVc (mean ± sD) 79.85 ± 6.15 67.88 ± 15.81 0.001*
rV (mean ± sD) 2.38 ± 0.97 3.75 ± 1.75 0.04*
Note: *P , 0.05.
Abbreviations: FVc, forced vital capacity; FeV1, forced expiratory volume in 1 second; rV, residual volume; sD, standard deviation.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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lightly throughout the procedure. Bronchoscopy was car-
ried out using a flexible fiberoptic bronchoscope (BF1T; 
Olympus, Tokyo, Japan) passed through the airway to reach 
the segmental and subsegmental carinae, and endobronchial 
biopsy specimens were taken from these regions using 
bronchoscopic forceps (Olympus). Supplemental oxygen 
was given throughout the procedure, and oxygen saturation 
was checked at regular intervals by a pulse oximeter until 
the subjects regained consciousness.
Two biopsy samples were taken from each patient, and 
were immediately and separately immersed in Tripure iso-
lation reagent (Roche, Mannheim, Germany) and formalin 
(Merck, Darmstadt, Germany). The samples in Tripure were 
stored at −80°C until RNA extraction, and the formalin 
samples were kept at 4°C for immunohistochemistry.
reverse transcriptase polymerase  
chain reaction analysis of MT-1A  
gene expression
We have already described the reverse transcriptase poly-
merase chain reaction procedure used in this study.11 In brief, 
all the RNA contained in the airway biopsy specimens was 
harvested in Tripure isolation reagent in accordance with 
the manufacturer’s protocol and kept at −80°C during the 
procedure. The RNA extracted was evaluated by Nanodrop 
spectrophotometer (ND-1000; Wilmington, DE), and its 
quality was confirmed by electrophoresis in 1% agarose gel 
(Cinnagen, Tehran, Iran). Aliquots of 500 ng of isolated 
RNA were utilized as templates for cDNA synthesis by 
SuperScript III reverse transcriptase (Invitrogen, Carlsbad, 
CA) following the manufacturer’s instructions.
Semiquantitative reverse transcriptase polymerase 
chain reaction for the MT-1A gene was carried out using 
equal amounts of synthesized cDNA, in a final reaction 
volume of 25 µL. All reagents and recombinant Taq DNA 
polymerase were obtained from Cinnagen, and the   reactions 
were done in a master cycler thermal cycler. Specific prim-
ers for MT-1A and β-actin (as a housekeeping gene) were 
designed using primer3 software (http://frodo.wi.mit.
edu/) and ordered from Bioneer (Daejeon, South Korea, 
see Table 2). The polymerase chain reaction conditions 
comprised primary denaturation at 94°C for 5 minutes, fol-
lowed by 30 polymerase chain reaction cycles comprising 
denaturation at 94°C for 30 seconds, annealing at 59°C (both 
genes at the same temperature) for 30 seconds, extension 
at 72°C for 60 seconds, followed by 5 minutes of terminal 
extension at 72°C. Finally, the polymerase chain reaction 
products were electrophoretically separated in 2% agarose 
gel and dyed with ethidium bromide (Cinnagen). Bands 
were visualized under ultraviolet light in gel documentation 
(Bio-RadLaboratories, Hercules, CA).
Quantitative real-time reverse transcriptase polymerase 
chain reaction was then performed in a Rotor-Gene RG 3000 
(Corbett Research, Mortlake, Australia). The amplification 
procedure, run in triplicate for each sample, used SYBR 
Green Premix (Takara Holdings, Inc, Shiga, Japan) according 
to the manufacturer’s instructions. Quantitative polymerase 
chain reaction criteria comprised initial denaturation at 94°C 
for 1 minute, followed by 40 amplification cycles, including 
denaturation at 94°C for 20 seconds, annealing at 59°C for 
30 seconds, and extension at 72°C for 30 seconds. β-actin 
gene expression was used to normalize threshold cycle   values 
(Ct) of the target gene, MT-1A, and provided us with a con-
trol for relative quantitative evaluation of the abundance of 
transcripts using the 2−∆∆CT method.
Immunohistochemistry
We have described the immunohistochemistry procedures 
used in this study in detail elsewhere.18 Briefly, 10 airway 
biopsy samples from sulfur mustard-injured patients and 
10 specimens from unexposed controls were examined. 
All samples were fixed in 4% formalin (Merck) and then 
immersed in phosphate-buffered saline (Takara   Holdings, 
Inc) containing 30% sucrose (Wako, Osaka, Japan). 
  Water-embedded sections 15 µm thick were prepared by 
cryostat (Histo-line, Milan, Italy), and incubated at 4°C with 
primary antibody at a dilution of 1:200 in phosphate-buffered 
saline for 12 hours. The primary antibody was a mouse 
monoclonal antibody raised against the human MT-1 isoform 
Table 2 sequence and features of Pcr
Gene (gene bank ID) Primer sequence (5′ to 3′) Annealing Tm (°C) Product size (bp)
MT-1A (NM_005946)
  Forward: ATGGAccccAAcTGcTccTGc 59 177
  reverse: cAGcTGcAcTTcTcTGATGccc
β-actin (NM_001101)
  Forward: TTcTAcAATGAGcTGcGTGTGG 59 119
  reverse: GTGTTGAAGGTcTcAAAcATGATInternational Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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(Abcam, Cambridge, UK). Next, the sections were incubated 
with biotinylated antimouse secondary antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA), and diluted to 1:200 for 
immunostaining. The sections were visualized using the 
mouse ABC staining system (Santa Cruz Biotechnology), 
and using 3,3’-diaminobenzidine as the substrate.
statistical analysis
Data were calculated as mean ± the standard deviation 
of fold-changes in MT-1A gene expression in three inde-
pendent experiments. SPSS software (v 15.0; SPSS, Inc, 
Chicago, IL) was used for the statistical analyses. Student’s 
t-test was used for the evaluation of differences in gene 
expression between the sulfur mustard-injured group and 
the unexposed group, and P , 0.05 was considered to be 
statistically significant.
Results
In total, 39 subjects participated in this study, comprising 
24 sulfur mustard-injured patients and 15 normal unex-
posed control individuals. The average age of the sulfur 
mustard-injured patients and the unexposed controls was not 
significantly different (42.9 versus 43.6 years, respectively, 
P = 0.83, see Table 1).
The results of pulmonary function testing are shown in 
Table 1. Although forced vital capacity in the control group 
was higher than in sulfur mustard-injured cases, the dif-
ference was not statistically significant (P = 0.11). On the 
other hand, forced expiratory volume in 1 second (FEV1) in 
the sulfur mustard group was significantly lower than in the 
controls (P = 0.007). Moreover, FEV1/forced vital capacity 
also differed between the two groups, being significantly 
higher in the controls (P = 0.001). Residual volume was 
significantly elevated in sulfur mustard-injured patients in 
comparison with controls (P = 0.43).
We initially used a semiquantitative reverse transcriptase 
polymerase chain reaction to elucidate whether there were 
any variations in MT-1A gene expression among the control 
samples, and our results revealed no significant differences 
(data not shown).
Next, we examined the expression of MT-1A in the sulfur 
mustard-injured patients. Because the controls had expressed 
identical levels of the gene, all of them were used for com-
parison with the results in the sulfur mustard-injured group. 
Our data revealed that MT-1A mRNA is upregulated in sulfur 
mustard-injured patients (Figure 1). The expression of MT-1A 
was also quantitatively evaluated by real-time reverse tran-
scriptase polymerase chain reaction. The results showed that 
expression of this gene at the mRNA level is 4.0 ± 2.60 times 
higher in sulfur mustard-injured patients in comparison with 
control samples (P = 0.001, see Table 3).
Immunohistochemistry was employed for evaluation and 
localization of MT-1 protein expression in airway biopsy 
samples from the two groups. It was immediately observed 
that the thickness of the bronchial epithelium layer in sulfur 
mustard-exposed patients was about twice that in normal 
control biopsies. In the control group, strong MT-1 immuno-
reactivity was seen in airway epithelium cells, especially in 
the basal (germinal) layer (Figures 2A and 2C). In contrast, 
in sulfur mustard-injured specimens, very weak MT-1 protein 
expression was seen in the bronchial epithelial cells, espe-
cially at the luminal side of the brush border cells, indicating 
very low MT-1 protein expression (Figures 2B and 2D).
Discussion
Bronchiolitis obliterans is the major long-term pulmonary 
complication in Iranian victims of sulfur mustard exposure,5 
but the exact molecular mechanisms involved in the symp-
toms observed need to be clarified. Air trapping in expiratory 
high-resolution computed tomography scans (data not shown) 
200 bp
100 bp
MT-1A (177 bp)
β-actin (119 bp)
M 1 2 34 56 7 8 910 11 12
Figure 1 MT-1A gene expression in sM-injured patients and in unexposed control cases. Gene expressions were measured by semiquantitative reverse transcriptase 
polymerase chain reaction, and were upregulated in sM-injured patients (lanes 3–12). Normal samples (lanes 1 and 2), sM-injured patients samples (lanes 3–13).
Abbreviations: sM, sulfur mustard; M, 100 bp marker; MT, metallothionein.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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was the most common finding in our sulfur   mustard-exposed 
patients. Pulmonary function test results showed an airflow 
obstruction pattern highly indicative of bronchiolitis obliterans 
as the major chronic pulmonary disorder in these patients.
Moreover, our semiquantitative reverse   transcriptase poly-
merase chain reaction results, confirmed by quantitative real- 
time reverse transcriptase polymerase chain reaction, indicate 
that expression of MT-1A at the mRNA level was significantly 
elevated in bronchial biopsy samples from the sulfur mustard-
exposed group in comparison with the unexposed controls. 
As far as we are aware, very little is known about the precise 
molecular mechanisms involved in the structural modifications 
and pathophysiological symptoms of late complications of 
sulfur mustard exposure, and there are no published reports con-
cerning MT-1A expression and its interaction with the delayed 
respiratory difficulties arising from sulfur mustard exposure.
A number of studies have shown that oxidative stress 
plays an important role in the pathogenesis of various lung 
diseases, including chronic obstructive pulmonary disease and 
asthma.20–21 Consistent with these findings, Ghanei et al22 have 
hypothesized that the long-term pulmonary complications 
of sulfur mustard exposure are neutrophil-dominant and/or 
lymphocyte-dominant disorders. It has also been shown that 
oxidative stress due to excessive production of reactive sub-
stances and depletion of endogenous antioxidants plays an 
important role in the pathogenesis of these delayed pulmonary 
sequelae.10,23 The recent finding that sulfur mustard increases 
endogenous production of reactive oxygen species suggests 
that reactive oxygen species are likely to be involved in the 
toxicity induced by this chemical warfare agent.7,8
The antioxidant activity of MT-1 was first demonstrated 
by Thornalley and Vasak,24 and it has since been proposed 
that MT-1 is involved in protection against damage caused by 
oxidative stress. Although the exact mechanism of the free 
radical scavenging action of MT-1 is not fully described, it 
has been postulated that MT-1 cysteine residues can react 
directly as thiolate groups with a number of reactive sub-
stances, as well as with hydroxyl radicals, peroxyl radicals, 
superoxide hydrogen peroxide, and nitric oxide.25–27
Pitt et al28 demonstrated that overexpression of MT 
decreases the sensitivity of pulmonary endothelial cells 
to oxidative damage. They showed that pulmonary artery 
endothelial cells in sheep transfected by both human and 
mouse MT were more resistant to tert-butyl hydroperoxide, 
an oxidant-generating substance, and were also more resis-
tant to hyperoxia. They suggested that MT can defend this 
cell type from attack by a variety of pro-oxidants. In another 
study, Wesselkamper et al29 showed that MT-1/2 transgenic 
mice had more resistance to nickel-induced acute lung 
injury than did MT-1/2 knockout mice, implying that MT 
can improve survival and inhibit progression of acute lung 
injury. More recently, an in vivo study by Helal and Helal30 
demonstrated that intraperitoneal administration of MT can 
protect rats against carmustine-provoked lung injury because 
of its antioxidant attributes and its ability to suppress tumor 
necrosis factor alpha.
Upregulation of MT-1A mRNA in the airways of sulfur 
mustard-injured patients, in addition to oxidative stress, 
could be due to inflammation. Some in vivo experiments 
have demonstrated that a number of pro-inflammatory 
cytokines, as well as tumor necrosis factor alpha, interleukin 
(IL)-1, IL-6, and interferon gamma can induce MT gene 
expression.31–33 Depending on the site, stimulus direction, 
and type of pathophysiologic situation, MT can have diverse 
anti-inflammatory roles.34 Emad and Emad35 evaluated levels 
of several cytokines in bronchoalveolar lavage fluid from 
Table 3 Increases in MT1A expression in sulfur mustard-exposed 
patients in comparison with control group
Case group/gene SM-exposed cases vs 
unexposed cases
P (t-test)
MT-1A 4.0 ± 2.60 0.001*
A B
L L
Bm
Bm
10 µ
C D
20 µ
10 µ
20 µ
Figure 2 Immunohistochemical staining for MT-1A protein in bronchial epithelium. 
Left side micrographs reveal the expression of MT-1A in the basal cell layer of control 
group airway epithelium (arrow, A and C). right side micrographs show MT-1A 
expression in sM-injured airway epithelium (B and D). Note the immunoreactivity 
of MT-A1 in the control group is higher and wider than in the sM-injured samples. In 
the high and same magnification the epithelium layer thickness in SM-injured is much 
thicker than control group (C and D).
Abbreviations: L, airway lumen; Bm, basement membrane; MT, metallothionein; 
sM, sulfur mustard.International Journal of General Medicine 2011:4 submit your manuscript | www.dovepress.com
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sulfur mustard-exposed patients and demonstrated that IL-8, 
IL-1β, IL-6, IL-12, and tumor necrosis factor alpha levels in 
sulfur mustard-injured patients were all significantly higher 
than in controls, and suggested that neutrophilic pulmo-
nary inflammation is possibly the mechanism underlying 
the long-term pulmonary complications of sulfur mustard 
exposure. Molecular level investigation of the existence 
of inflammation in the airways of sulfur mustard-injured 
patients is underway in our laboratory, and preliminary, as 
yet unpublished data show that tumor necrosis factor alpha 
expression at the mRNA level is significantly upregulated in 
sulfur mustard-exposed patients in comparison with controls, 
suggesting that inflammatory processes are involved in this 
chronic pulmonary complication. Consistent with these 
findings, Takano et al36 have shown that MT-1/2 knockout 
mice are more vulnerable to acute pulmonary inflammatory 
injury mediated by intratracheal instillation of lipopolysac-
charide than wild-type mice. Additionally, in line with these 
findings, a complementary DNA microarray study based 
on acute inflammatory murine lung damage induced by 
lipopolysaccharide and diesel exhaust particles revealed that 
MT-1 gene expression at the mRNA level is significantly 
upregulated in mice exposed to these irritants.17 Similarly, a 
more recent study showed that MT plays an important role 
in ozone-induced pulmonary inflammation, and showed that 
lung inflammation is significantly greater in MT-1/2 knockout 
than wild-type mice.37 However, despite numerous investiga-
tions of the possible contribution of MT-1 to inflammatory 
lung injuries, its exact role still needs to be elucidated.
Paradoxically, our immunohistochemistry results 
revealed that, in contrast with the upregulation of MT-1A 
mRNA expression in airway biopsy samples from sulfur 
mustard-injured patients, its protein level was higher in 
control subjects. Several MT-1 immunoreactive cells were 
seen in the bronchial epithelia of our control cases, and 
immunoreactivity was more intense in cells adjacent to the 
basement membrane. This finding is in accordance with that 
of Courtade et al,38 who evaluated the expression of MT in 
the normal human lung, and observed positively stained 
pleural endothelial cells and basal cells from the bronchial 
epithelium. In contrast, in our chemically-injured cases, only 
a very weak expression of MT-1 was observed on the luminal 
side of the bronchial epithelium. We have also already shown 
an inconsistency between mRNA and protein expression of 
lipocalin-2 and heme oxygenase in the bronchial epithelium 
of sulfur mustard-exposed patients compared with unexposed 
cases.11,39,40 We hypothesize that this discrepancy between 
mRNA and protein expression of MT-1A may be caused by 
translational inefficiency and/or posttranslational   regulation. 
Interestingly, it has been revealed that, despite a huge amount 
of evidence strongly suggesting that the expression of MT 
genes is transcriptionally regulated, new data have also 
indicated that posttranslational modulations also have effects 
on MT gene expression.14 This discrepancy may be due to a 
change in the expression of microRNAs, which are posttran-
scriptional regulators that bind to complementary sequences 
on target messenger RNA transcripts, usually resulting in 
translational repression and gene silencing.41
Intriguingly, it has been shown that administration of 
N-acetylcysteine can significantly improve clinical symptoms 
in sulfur mustard-exposed patients,19 and it has also been 
demonstrated that N-acetylcysteine, as an antioxidant, pro-
vides thiol groups which are essential for serum glutathione 
production.39 In this way, N-acetylcysteine can compensate 
for decreased expression of MT-1 protein, but, in spite of 
this improvement, no cure has as yet been achieved in sulfur 
mustard-injured patients.
Conclusion
This study shows that although the expression of MT-1 at 
the mRNA level was significantly increased in the bronchial 
epithelium of sulfur mustard-exposed patients, expression of 
MT-1 protein was significantly higher in the airways of our 
controls. This upregulation of MT-1 mRNA seems to be due 
to oxidative stress and depletion of the endogenous antioxi-
dants which exist in the lungs of patients who have inhaled 
sulfur mustard, and may reflect an attempt to ameliorate this 
harmful situation by reestablishment of homeostasis. The 
contrasting depletion of its protein may be a result of sec-
ondary effects of sulfur mustard toxicity. Therefore, further 
studies clarifying the mechanisms involved in the long-term 
outcome of sulfur mustard exposure are warranted.
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